Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
Loss of sense of smell and taste has been anecdotally reported during the covid-19 epidemic. The study investigators wanted to describe the prevalence of olfactory and gustatory dysfunction and assess the factors associated with positive SARS-CoV-2 infection.
Description: Positive/negative according to RT-PCR assay
Measure: SARS-CoV-2 infection status Time: Day 0Description: Custom-designed questionnaire (28 questions pertaining to symptoms, sense of smell and taste)
Measure: Olfactory and gustatory loss Time: Day 0Description: Ability to smell 1.5ml air freshner on a 0-100 VAS scale
Measure: Ability to detect odor Time: Day 0Description: Ability to smell 1.5ml air freshner on a 0-100 VAS scale
Measure: Ability to detect odor Time: Six monthsDescription: Ability to taste a pinch of table salt on a 0-100 VAS scale
Measure: Ability to detect salty taste Time: Day 0Description: Ability to taste a pinch of table salt on a 0-100 VAS scale
Measure: Ability to detect salty taste Time: Six monthsDescription: Ability to taste a pinch of sugar on a 0-100 VAS scale
Measure: Ability to detect sweet taste Time: Day 0Description: Ability to taste a pinch of sugar on a 0-100 VAS scale
Measure: Ability to detect sweet taste Time: Six monthsDescription: Custom-designed questionnaire (28 questions pertaining to symptoms, sense of smell and taste)
Measure: Olfactory and gustatory loss Time: Day 7Description: Custom-designed questionnaire (28 questions pertaining to symptoms, sense of smell and taste)
Measure: Olfactory and gustatory loss Time: Day 14Description: Custom-designed questionnaire (28 questions pertaining to symptoms, sense of smell and taste)
Measure: Olfactory and gustatory loss Time: Day 30Description: Custom-designed questionnaire (28 questions pertaining to symptoms, sense of smell and taste)
Measure: Olfactory and gustatory loss Time: Day 60Description: % patients hospitalized
Measure: Severity of infection according to hospitalization rate Time: End of study (six months)Description: Custom-designed questionnaire (28 questions pertaining to symptoms, sense of smell and taste)
Measure: Olfactory and gustatory loss Time: Six monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports